Sign in

CIK 0001737287 · Non-accelerated filer<br>Smaller reporting company

Allogene Therapeutics, Inc.

Sign in to watch
Ticker
ALLO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
823562771
Phone
(650) 457-2700
Business address
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Derivatives Options or other derivatives
  2. 8-K Event Shareholder vote results
  3. 4 Planned sale Director sold 36,885 shares at $1.42 ($52,377)
  4. 144 Insider Sale of Securities
  5. 10-Q Report Quarterly Report
  6. 8-K Event Results of operations
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  10. ARS Other Annual Report to Security Holders
  11. DEFA14A Proxy Proxy Materials
  12. DEF 14A Proxy Proxy Statement
  13. 4 Open-market sale SVP, Finance sold 9,601 shares at $1.41 ($13,537)
  14. 144 Insider Sale of Securities
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. 4 Open-market sale President and CEO sold 46,668 shares at $1.96 ($91,469)
  17. 4 Open-market sale SVP, Chief Technical Officer sold 5,488 shares at $1.98 ($10,839)
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 6 of 30 · 587 filings